20多年來，羅氏致力于為血液病患者開發藥物，在這一治療領域積累了豐富的經驗與知識。現如今，羅氏的投入遠超以往，努力為各類血液病患者提供創新的治療選擇。目前公司獲批的藥物包括美羅華^{®<\/sup>（利妥昔單抗）、佳羅華^{®<\/sup>（奧妥珠單抗）、優羅華^{®<\/sup>（維泊妥珠單抗）、高羅華^{®<\/sup>（格菲妥單抗），皓羅華^{®<\/sup>（莫妥珠單抗）和舒友立樂^{®<\/sup>（艾美賽珠單抗）。羅氏的科學專業知識，加上廣泛的產品組合和產品線，也為開發進一步改善患者生活的聯合治療方案提供了獨特的機會。<\/p> \n}}}}}}

羅氏是一家全球領先的生物技術企業，總部在瑞士，擁有125余年悠久歷史。結合制藥和診斷兩大領域的獨特優勢，我們致力于通過個體化醫療推動科學進步，改善人類生活。作為全球制藥和診斷領域的領導者，羅氏在抗腫瘤、免疫、抗感染、眼科和神經科學系統領域擁有一流的差異化藥物。創新是羅氏的DNA。作為一家以創新為驅動的制藥公司，每年，羅氏集團在研發創新領域投入巨大。2021年，羅氏全球的研發投入達到150億美元，約占公司收入的20%。<\/p> \n

\n \n \n \n \n \n \n \n
<optgroup id="kgssg"></optgroup>
<center id="kgssg"></center>
久久久亚洲欧洲日产国码二区

^{[1]<\/sup> <\/span> FDA approves Roche's Columvi, the first and only bispecific：https:\/\/www.globenewswire.com\/news-release\/2023\/06\/16\/2689505\/0\/en\/FDA-approves-Roche-s-Columvi-the-first-and-only-bispecific-antibody-with-a-fixed-duration-treatment-for-people-with-relapsed-or-refractory-diffuse-large-B-cell-lymphoma.html<\/a> <\/span> <\/p> <\/td> \n <\/tr> \n}

^{[2]<\/sup> <\/span> Coiffier B, et al. Blood. 2010;116(12):2040-2045.<\/span> <\/p> <\/td> \n <\/tr> \n}

^{[3]<\/sup> <\/span> Hoffmann MS, et al. Transplant Cell Ther. 2023;29(7):440-448.<\/span> <\/p> <\/td> \n <\/tr> \n}

^{[4] <\/sup> <\/span>Abramson JS, Ku M, Hertzberg M, et al. Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial. Lancet. 2024;404(10466):1940-1954. doi:10.1016\/S0140-6736(24)01774-4<\/span> <\/p> <\/td> \n <\/tr> \n}

^{[5]<\/sup> <\/span> Roche's Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma：https:\/\/www.roche.com\/media\/releases\/med-cor-2024-06-15#:~:text=Basel%2C%2015%20June%202024%20-%20Roche%20%28SIX%3A%20RO%2C,2024%20Congress%20as%20a%20late-breaking%20oral%20presentation.%201<\/a> <\/span> <\/p> <\/td> \n <\/tr> \n <\/tbody> \n <\/table> \n<\/div> \n}
<\/p> \n $\"\"$ "]; $("#dvExtra").html(content_array[0]);})();
<center id="kgssg"></center>